Not sure if TMS would help you?

We offer genetic testing through Genomind to help identify patients that may have an improved response to Transcranial Magnetic Stimulation (TMS).  Research suggests that individual’s with certain genetic variants analyzed by the Genecept Assay are likely to respond well to Transcranial Magnetic Stimulation (TMS).

About the Genecept Assay®

The Genecept Assay is a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes that have been selected based on hundreds of studies showing that variations in these genes can inform treatment decisions. The Assay is used to guide treatment for a range of psychiatric conditions, including depression, anxiety, obsessive-compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD), bipolar disorder, post-traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain and substance abuse, and has been shown in peer-reviewed published studies to improve patient outcomes and reduce overall medical costs. Each Assay provides clinicians with an easy-to-read patient report and a complimentary psychopharmacogenomic consultation. Learn more at

Please contact our office if you are interested.

Genetic testing is covered by some insurances at no cost or if it is not covered Genomind offers financial assistance and coverage.